UCB Receives FDA Clearance for Innovative ZILBRYSQ® Autoinjector Targeting Myasthenia Gravis Treatment #USA #Atlanta #UCB #Myasthenia_Gravis #ZILBRYSQ
@newsen.bsky.social
@newsen.bsky.socialUCB Receives FDA Clearance for Innovative ZILBRYSQ® Autoinjector Targeting Myasthenia Gravis Treatment #USA #Atlanta #UCB #Myasthenia_Gravis #ZILBRYSQ
@newsen.bsky.socialUCB's Innovative Approaches to Treating Generalized Myasthenia Gravis Highlighted at AANEM 2026 #United_States #Orlando #UCB #GMG #ZILBRYSQ